Session Information
Date: Tuesday, November 7, 2017
Title: Plenary Session III
Session Type: ACR Plenary Session
Session Time: 11:00AM-12:30PM
Background/Purpose:
Synovitis is a common feature in meniscal tear (MT) and osteoarthritis (OA). Synovitis has been associated with progression of cartilage damage in persons with OA, as has arthroscopic partial meniscectomy (APM), a frequent treatment for MT. It is unknown whether the presence or the persistence of effusion-synovitis is associated with changes in cartilage damage in patients with concurrent MT and OA.
Methods:
We used data from the Meniscal Tear in Osteoarthritis Research (MeTeOR) Trial of APM vs. physiotherapy (PT). Subjects were ≥45 years old, had MT on MRI, OA on MRI or radiograph, and knee symptoms. Subjects crossing-over between treatment groups or without both baseline and 18mo MRI were excluded. MRIs were read using the MRI OA Knee Score (MOAKS). Baseline effusion-synovitis was dichotomized as none/mild (0) and moderate/severe (1). Change in effusion-synovitis over 18mo was categorized as never developed (0 at baseline, 0 at 18mo), intermittent (1 at only 1 time point), and persistent (1 at baseline, 1 at 18mo). Change in cartilage damage over 18mo was examined in 14 subregions and assessed by a) number of subregions with worsening (subregions grade ≥1 at baseline with increased surface area affected by full thickness loss) and b) number of additional subregions affected (subregions grade 0 at baseline with new full thickness loss). Both outcomes were specified as binary (0 regions vs. 1+). We used logistic regression to investigate the associations between a) baseline effusion and b) change in effusion on both cartilage damage outcomes over 18mo in 4 individual models – with adjustment for differences in treatment (APM vs. PT), sex, BMI, and baseline cartilage damage.
Results:
We analyzed 174 knees (1/person), 102 had APM and 72 PT. Moderate/severe effusion was observed in 48% patients at baseline and 29% at 18mo. Fifty-six percent of subjects had subregions with worsening and 45% had additional subregions affected. Over 18mo, 44% subjects never developed effusion, 35% had intermittent effusion, and 21% had persistent effusion. Overall participants were 59% female, 58 years old, with a BMI of 30 kg/m2. Compared to subjects who never developed effusion, those with intermittent effusion had 2.6-fold (95% CI 1.2, 5.5) greater odds of worsening cartilage damage, while those with persistent effusion had 4.5-fold (95% CI 1.6, 12.8) greater odds. Similar results were obtained for analyses of baseline effusion and number of additional subregions affected (Table).
Conclusion:
Effusion-synovitis status at baseline and 18mo was associated with worsening of cartilage damage at 18mo in patients with MT and OA, independent of study treatment. The risk of cartilage damage was greater in those with persistent effusion than in those with intermittent effusion. If confirmed in other studies, these findings would support research on the structural effects of interventions to reduce effusion in this population.
Table: Odds ratios from logistic regression of A) Baseline and B) Change in Effusion-Synovitis on Cartilage Damage over 18 months |
||||
A. Baseline Effusion-synovitis | ||||
N |
1+ subregion with worsening cartilage damage* Odds Ratio (95% CI) |
1+ additional subregion affected by cartilage damage* Odds Ratio (95% CI) |
||
Baseline Effusion-synovitis |
|
|||
None/mild |
92 |
REF |
REF |
|
Moderate/severe |
84 |
2.9 (1.4, 5.9) |
2.8 (1.4, 5.5) |
|
|
||||
B. 18 Month Change in Effusion-synovitis | ||||
|
N |
1+ subregion with worsening cartilage damage* Odds Ratio (95% CI) |
1+ additional subregion affected by cartilage damage* Odds Ratio (95% CI) |
|
Change in Effusion-synovitis |
|
|||
Never Developed |
77 |
REF |
REF |
|
Intermittent |
61 |
2.6 (1.2, 5.5) |
2.2 (1.1, 4.7) |
|
Persistent |
36 |
4.5 (1.6, 12.8) |
4.0 (1.5, 10.3) |
|
*all models adjusted for treatment (APM vs PT), sex, BMI and baseline cartilage damage Change in effusion-synovitis: never developed (none/mild at baseline and 18mo), intermittent (mod/severe at only 1 time point), persistent (mod/severe at baseline and 18mo) |
To cite this abstract in AMA style:
MacFarlane LA, Yang HY, Collins JE, Jarraya M, Guermazi A, Mandl LA, Losina E, Katz JN. Effect of Baseline and Change in Effusion-Synovitis on Cartilage Damage over 18 Months in Patients with Osteoarthritis and Meniscal Tear [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/effect-of-baseline-and-change-in-effusion-synovitis-on-cartilage-damage-over-18-months-in-patients-with-osteoarthritis-and-meniscal-tear/. Accessed .« Back to 2017 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-baseline-and-change-in-effusion-synovitis-on-cartilage-damage-over-18-months-in-patients-with-osteoarthritis-and-meniscal-tear/